Page last updated: 2024-09-02
triptolide and am 630
triptolide has been researched along with am 630 in 1 studies
Compound Research Comparison
Studies (triptolide) | Trials (triptolide) | Recent Studies (post-2010) (triptolide) | Studies (am 630) | Trials (am 630) | Recent Studies (post-2010) (am 630) |
---|---|---|---|---|---|
1,158 | 6 | 820 | 281 | 1 | 194 |
Protein Interaction Comparison
Protein | Taxonomy | triptolide (IC50) | am 630 (IC50) |
---|---|---|---|
Cannabinoid receptor 2 | Homo sapiens (human) | 7.2 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
DeLeo, JA; Landry, RP; Martinez, E; Romero-Sandoval, EA | 1 |
Other Studies
1 other study(ies) available for triptolide and am 630
Article | Year |
---|---|
Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain.
Topics: 4-Nitrophenylphosphatase; Animals; Disease Models, Animal; Diterpenes; Dual Specificity Phosphatase 1; Dual Specificity Phosphatase 6; Epoxy Compounds; Gene Expression Regulation; Hyperalgesia; Immunosuppressive Agents; Indoles; Male; Mitogen-Activated Protein Kinase Phosphatases; Nerve Tissue Proteins; Neuralgia; Phenanthrenes; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Signal Transduction; Spinal Cord; Time Factors | 2012 |